Terapia con células madre: A Novel Approach for Early-Stage Chronic Kidney Disease
Enfermedad renal crónica (ERC) es un problema de salud mundial, afectando a millones en todo el mundo. Current treatment options for CKD are limited, and most patients eventually progress to end-stage renal disease (ESRD) que requieren diálisis o trasplante. Terapia con células madre has emerged as a promising approach for treating early-stage CKD, offering the potential to repair damaged kidney tissue and restore function.
Explorando el potencial de las células madre en la reparación del riñón
Stem cells are undifferentiated cells that have the ability to develop into various specialized cell types. En el contexto de la ERC, Las células madre pueden derivarse de diversas fuentes., incluyendo la médula ósea, tejido adiposo, and the kidneys themselves. These stem cells can be directed to differentiate into functional kidney cells, como los podocitos y las células epiteliales tubulares., which are crucial for kidney function. By replacing damaged or lost kidney cells, stem cells can potentially restore kidney function and slow or halt the progression of CKD.
